UFO Moviez Q1FY27: consol PAT falls 13.5% YoY to ₹5.64 Cr on margin compression

UFO Moviez's consolidated PAT for Q1 FY27 (quarter ended June 30, 2026) came in at ₹5.64 Cr, down 13.5% year-on-year from ₹6.52 Cr in Q1 FY26, even though consolidated revenue from operations grew 3.8% YoY to ₹110.69 Cr from ₹106.63 Cr. Profit growth trailing revenue growth is the headline: consolidated EBITDA margin compressed to 17.03% from 18.09% a year ago, and net margin fell to 5.09% from 5.84%, as depreciation (up 3.8% YoY to ₹10.47 Cr) and finance costs (up 5.1% YoY to ₹3.29 Cr) grew faster than operating profit. There were no exceptional items in either period, so the YoY decline sits on a clean base rather than a one-off distortion. On a standalone basis, PAT was ₹4.10 Cr on revenue of ₹91.96 Cr; the ₹1.54 Cr gap to the consolidated figure comes from subsidiaries and a ₹0.39 Cr share of associates' profit — the standalone print doesn't have a year-ago column in the comparison set, but the consolidated numbers (the primary basis) clearly show compression, so there is no material divergence in the underlying story. Sequentially, the standalone print looks stronger — PAT rose to ₹4.10 Cr from ₹2.01 Cr in Q4 FY26 even as revenue fell 12.6% QoQ (₹91.96 Cr vs ₹105.27 Cr). This is an opex-timing artifact rather than a genuine trend: Q4 FY26 carried much heavier digital-cinema equipment and lamp purchases (₹17.00 Cr versus ₹7.40 Cr this quarter), which depressed that quarter's margins, so the QoQ jump should not be read as a turnaround. Management's Q4 FY26 concall struck a confident, optimistic tone, citing a robust content pipeline and strengthening advertising/premium-cinema initiatives to sustain FY26's momentum (FY26 PAT had grown 161% to ₹24.9 Cr); this quarter's soft 3.8% revenue growth and 13.5% PAT decline run behind that narrative, so the print reads as a miss against the qualitative bar management set, even though no numeric target was given. No brokerage consensus estimate specific to this quarter turned up in a web search, so the print cannot be benchmarked against a Street number; recent analyst ratings on the stock skew toward Sell, unrelated to this print. No separate management press release or commentary accompanied this filing to quote or reconcile against. This quarter's corporate calendar items — the AGM set for August 19, 2026 and the trading-window closure ahead of results — are procedural and not tied to the operating numbers.